Oral treatments for toenail onychomycosis: A systematic review

Archives of Dermatology

Volumn 138, Issue 6, 2002, Pages 811-816

  Crawford, Fay ^a   Young, Philip ^b   Godfrey, Christine ^b   Bell Syer, Sally E M ^b   Hart, Rachel ^c   Brunt, Elizabeth ^b   Russell, Lan ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c London Foot Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; PLACEBO; TERBINAFINE;

ANTIBIOTIC THERAPY; ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHYTE; DOSE CALCULATION; DRUG EFFICACY; DRUG INDUCED DISEASE; EVIDENCE BASED MEDICINE; HUMAN; ONYCHOMYCOSIS; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; TOE;

ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; FEMALE; FOOT DERMATOSES; GRISEOFULVIN; HUMANS; ITRACONAZOLE; KETOCONAZOLE; MALE; NAPHTHALENES; ONYCHOMYCOSIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0036282632     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Treatment of toenail onychomycosis: Do crinkly toenails really matter?
2. Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey
3. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
4. Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists
5. Improving the quality of randomized controlled trials: The CONSORT statement
6. Meta-analysis in clinical trials
7. Itraconazole versus terbinafine (LAMISIL): Which is better for the treatment of onychomycosis?
8. Open randomized comparison of different itraconazole regimens for the treatment of onychomycosis
9. Itraconazole pulse therapy is effective in dermatophyte onychomycosis of the toenail: A double blind placebo controlled study
10. Double-blind randomized comparison of itraconazole capsules and placebo in onychomycosis of toenail
11. Double-blind randomized comparison of itraconazole capsules vs placebo in the treatment of toenail onychomycosis
12. Short term treatment of dermatophyte onychomycosis
13. Terbinafine in onychomycosis of the toenail: A novel treatment protocol
14. Oral terbinafine in toenail dermatophytosis: A double blind placebo controlled multi-centred study with 12 months' follow-up
15. Double blind, randomized study of continuous terbinafine compared with intermittent itraconazole in the treatment of toenail onychomycosis
16. Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis: A new approach
17. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy
18. Antifungal pulse therapy for onychomycosis: A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1 week pulse therapy with itraconazole
19. A double blind randomized study comparing itraconazole pulsed therapy with continuous dosing for the treatment of toenail onychomycosis
20. Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial
21. A randomized treatment duration-finding study of terbinafine in onychomycosis
22. Once weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail
23. Once weekly fluconazole (150, 300 or 450 mg) in the treatment of distal subungual onychomycosis of the toenail
24. Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosis
25. Ketoconazole and griseofulvin in the treatment of toenail dermatophyte onychomycosis
26. Efficacy and safety of itraconazole in the long-term treatment of onychomycosis
27. Itraconazole in onychomycosis: Open and double blind studies
28. German randomized double blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection
29. Open randomized comparison of itraconazole versus terbinafine in onychomycosis
30. Comparative multicentre double blind study of terbinafine (250 mg per day) versus griseofulvin (1 g per day) in the treatment of dermatophyte onychomycosis
31. Double-blind parallel group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis
32. Treatment of toenail onychomycosis: A randomized double blind study with terbinafine and griseofulvin
33. Trichophyton-rubrum infected toenails treated with ketoconazole and partial nail avulsion
34. Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole
35. Itraconazole in the treatment of onychomycosis: A double blind comparison with miconazole
36. Treatment of dermatophyte nail infections: An open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy
37. Terbinafine vs placebo for onychomycosis in black patients
38. A 12-week treatment for dermatophyte toe onychomycosis: Terbinafine 250 mg/day vs itraconazole 200 mg/day - A double-blind comparative trial
39. Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent
40. German randomized double blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection
41. Terbinafine versus itraconazole: A controlled clinical comparison in onychomycosis of the toenails
42. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis
43. Hepatic injury during ketoconazole therapy in patients with onychomycosis: A controlled cohort study
44. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: A double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day
45. A comparison among four regimens of itraconazole treatment in onychomycosis
46. Non-dermatophytes in onychomycosis of the toenails
47. Significance of non-dermatophyte moulds and yeasts in onychomycosis
48. Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis
49. Treatment of onychomycosis: A randomized double blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin
50. Treatment of dermatophyte infection of the finger- and toenails with terbinafine, an orally active fungicidal agent
51. Short duration therapy with terbinafine for dermatophyte onychomycosis: A multicentre trial
52. Itraconazole pulsed therapy vs continuous terbinafine dosing for toenail onychomycosis
53. Chronic ringworm infection of the skin and nails treated with griseofulvin: Report of a therapeutic trial
54. Nail incorporation kinetics of terbinafine in onychomycosis patients
55. Randomized double blind trial of the efficacy and tolerability of terbinafine 250 mg once daily versus 250 mg twice daily in the treatment of toenail onychomycosis for 16 weeks
56. Double-blind randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis